These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28638584)

  • 1. The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population.
    Rabiee B; Roozafzai F; Hemasi GR; Poustchi H; Keyvani H; Khonsari MR; Ajdarkosh H; Maadi M; Sima Saeedian F; Zamani F
    Middle East J Dig Dis; 2017 Apr; 9(2):86-93. PubMed ID: 28638584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-alcoholic fatty liver disease increases the incidence rate of type 2 diabetes mellitus: a cohort study based on a rural town elderly population of southern Jiangsu].
    Shao Y; Xu JY; Lu XL; Chen J; Li T; Wang YT; Shi HT
    Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):867-872. PubMed ID: 34638206
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study.
    Targher G; Mantovani A; Grander C; Foco L; Motta B; Byrne CD; Pramstaller PP; Tilg H
    Nutr Metab Cardiovasc Dis; 2021 Nov; 31(12):3464-3473. PubMed ID: 34627696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.
    Su X; Xu J; Zheng C
    BMC Endocr Disord; 2019 Jul; 19(1):76. PubMed ID: 31315613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus.
    Olusanya TO; Lesi OA; Adeyomoye AA; Fasanmade OA
    Pan Afr Med J; 2016; 24():20. PubMed ID: 27583084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes.
    Seo DH; Lee YH; Park SW; Choi YJ; Huh BW; Lee E; Huh KB; Kim SH; Cha BS
    Diabetes Metab; 2020 Oct; 46(5):362-369. PubMed ID: 31689496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
    Guo M; Xi G; Yang N; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of insulin resistance in the occurence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetes.
    Hazim A; Purnamasari D; Kalista KF; Lesmana CRA; Nugroho P
    Diabetes Metab Syndr; 2019; 13(2):1431-1435. PubMed ID: 31336502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and predictors of non-alcoholic fatty liver disease as defined by the fatty liver index in a type 2 diabetes population.
    Silaghi CA; Silaghi H; Colosi HA; Craciun AE; Farcas A; Cosma DT; Hancu N; Pais R; Georgescu CE
    Clujul Med; 2016; 89(1):82-8. PubMed ID: 27004029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of leukocyte telomere length with non-alcoholic fatty liver disease in patients with type 2 diabetes.
    Zhang M; Hu ML; Huang JJ; Xia SS; Yang Y; Dong K
    Chin Med J (Engl); 2019 Dec; 132(24):2927-2933. PubMed ID: 31809318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?
    Gutierrez-Buey G; Núñez-Córdoba JM; Llavero-Valero M; Gargallo J; Salvador J; Escalada J
    Eur J Intern Med; 2017 Jun; 41():74-78. PubMed ID: 28283346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes.
    Yamazaki H; Tsuboya T; Tsuji K; Dohke M; Maguchi H
    Diabetes Care; 2015 Sep; 38(9):1673-9. PubMed ID: 26156527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran.
    Mansour-Ghanaei F; Joukar F; Mobaraki SN; Mavaddati S; Hassanipour S; Sepehrimanesh M
    Diabetes Metab Syndr; 2019; 13(2):1591-1596. PubMed ID: 31336526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for non-alcoholic fatty liver disease in children and adolescents with type 1 diabetes mellitus: a cross-sectional analysis.
    Kummer S; Klee D; Kircheis G; Friedt M; Schaper J; Häussinger D; Mayatepek E; Meissner T
    Eur J Pediatr; 2017 Apr; 176(4):529-536. PubMed ID: 28213828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT).
    Kalra S; Vithalani M; Gulati G; Kulkarni CM; Kadam Y; Pallivathukkal J; Das B; Sahay R; Modi KD
    J Assoc Physicians India; 2013 Jul; 61(7):448-53. PubMed ID: 24772746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
    Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
    J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Liver Enzymes in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease.
    Mandal A; Bhattarai B; Kafle P; Khalid M; Jonnadula SK; Lamicchane J; Kanth R; Gayam V
    Cureus; 2018 Nov; 10(11):e3626. PubMed ID: 30697502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.